Provided by Tiger Trade Technology Pte. Ltd.

Incyte

115.30
-1.8400-1.57%
Post-market: 115.00-0.3000-0.26%17:48 EDT
Volume:2.17M
Turnover:250.62M
Market Cap:23.37B
PE:14.69
High:117.19
Open:116.76
Low:114.57
Close:117.14
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:1.30
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.68
PE(LYR):17.99

Loading ...

US FDA Approves Orca Bio's Blood Cancer Therapy

Reuters
·
Jul 01

Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 01

Incyte Price Target Maintained with a $140.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 29

Barclays Keeps Their Buy Rating on Incyte (INCY)

TIPRANKS
·
Jun 29

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Accenture, Estée Lauder, Luckin, Incyte, BILL Trending

TIPRANKS
·
Jun 27

Incyte Corp. Stock Rises 5.8%, Outperforms Peers

Dow Jones
·
Jun 27

Incyte is Maintained at Neutral by UBS

Dow Jones
·
Jun 27

Incyte Winds Down Itacitinib Rollover Study: What Investors Should Know

TIPRANKS
·
Jun 27

Movement Alert|Incyte Rises 5.84% in Regular Trading, Opzelura Receives Positive EU CHMP Opinion for Atopic Dermatitis

Market Focus
·
Jun 27

Incyte Shares Rise 5.2% After Co Announces Positive EU Regulatory Opinion for Opzelura Skin Disease Treatment

THOMSON REUTERS
·
Jun 26

Incyte to Present Phase 1/2 Vga039 Data in Von Willebrand Disease at ISTH Congress

Reuters
·
Jun 26

Incyte announces positive CHMP opinion of Opzelura Cream

TIPRANKS
·
Jun 26

Incyte Says EMA Panel Backs EU Approval of Opzelura Cream for Moderate Atopic Dermatitis in Adults

Reuters
·
Jun 26

Incyte Announces Positive Chmp Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

THOMSON REUTERS
·
Jun 26

Incyte (INCY) Lands Fresh Clinical Wins, Is It Fully Valued?

Simply Wall St.
·
Jun 26

UBS Adjusts Price Target on Incyte to $113 From $103

MT Newswires Live
·
Jun 25

Incyte Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

S&P 500 Futures Rise in Premarket Trading; Dick's Sporting Goods, Zimmer Biomet Holdings Lag

Dow Jones
·
Jun 24

Incyte Price Target Maintained with a $140.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 24